Zohar Attias-Geva

Metformin Downregulates the Insulin/IGF-I Signaling Pathway and Inhibits Different Uterine Serous Carcinoma (USC) Cells Proliferation and Migration in p53-Dependent or -Independent Manners

Rive Sarfstein, Yael Friedman, Zohar Attias-Geva et al. · PLoS ONE · 2013 · 151 citations · Full text

Medicine, Endocrinology, Oncology +17

p53 Regulates insulin-like growth factor-I receptor gene expression in uterine serous carcinoma and predicts responsiveness to an insulin-like growth factor-I receptor-directed targeted therapy

Zohar Attias-Geva, Itay Bentov, Dvora Kidron et al. · European Journal of Cancer · 2011 · 38 citations

Medicine, Cancer Biology, Oncology +14

Insulin-like growth factor-I receptor (IGF-IR) targeting with monoclonal antibody cixutumumab (IMC-A12) inhibits IGF-I action in endometrial cancer cells

Zohar Attias-Geva, Itay Bentov, Dale L. Ludwig et al. · European Journal of Cancer · 2011 · 37 citations

Medicine, Endocrinology, Oncology +14

Insulin-like growth factor-I receptor inhibition by specific tyrosine kinase inhibitor NVP-AEW541 in endometrioid and serous papillary endometrial cancer cell lines

Zohar Attias-Geva, Itay Bentov, Ami Fishman et al. · Gynecologic Oncology · 2011 · 30 citations

Medicine, Oncology, Pharmacology +12

IGF1R-directed targeted therapy enhances the cytotoxic effect of chemotherapy in endometrial cancer

Connie Bitelman, Rive Sarfstein, Menahem Sarig et al. · Cancer Letters · 2013 · 20 citations

Medicine, Oncology, Pharmacology +12